CCN1C(=O)C2(c3ccccc31)c1c(oc3ccccc3c1=O)C(=O)N2CCOC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?